Research analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Down 1.2 %
NASDAQ:RKDA opened at $5.01 on Friday. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The stock’s 50-day moving average price is $4.80 and its 200-day moving average price is $3.68. The stock has a market capitalization of $6.81 million, a PE ratio of -1.17 and a beta of 0.90.
Arcadia Biosciences Company Profile
See Also
- Five stocks we like better than Arcadia Biosciences
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Oilfield Leader SLB: An AI Name You Need to Know
- The Risks of Owning Bonds
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.